Clinical Trial Update: Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the neurophysiologic and clinical effects of a single-dose drug challenge in Fragile X Syndrome; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Fragile X Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING